World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 4.639

ICV : 78.6

Abstract

VITAMIN D AND ANDROGENS IN PROSTATE DISEASE PATIENTS

*Bistra Tzaneva Galunska, Bogdan Roussev Hadjiev, Daniela Ivanova Gerova, Alexander Ivanov Hinev, Natalya Vasilevna Usheva and Dobrin Avramov Svinarov

ABSTRACT

Aim: To study the relationship between vitamin-D status, androgens and clinical determinants for benign and malignant prostate diseases. Materials and methods: This prospective single-centred study includes 54 benign prostatic hyperplasia patients age-matched with 88 prostate cancer patients, selected by serum prostate specific antigen levels, digital rectal examination, and systemic transrectal tru-cut prostate biopsies. The cancer patients were stratified by the risk for biochemical recurrence after definite local treatment and by tumour’s Gleason score. Total and free testosterone, dehydroepiandrosterone sulphate, androstenedione, sex-hormone binding globulin, 25-hydroxyvitamin-D, and vitamin-D binding protein were measured. Results: Vitamin-D deficiency was more frequent in cancer patients vs noncancerous (69.4% vs 43.4%). Negative correlation (r=-0.255, p<0.05) and decrease (p=0.07) with the tumour grade was found for 25-hydroxyvitamin-D. Similar relationships were detected for free and total testosterone (p=0.08) and free androgen index (r=-0.262, p<0.05). Risk stratification revealed a decrease in 25-hydroxyvitamin-D (p<0.05) and vitamin-D binding protein (ns), while sex-hormone-binding protein (p<0.01) and prostate specific antigen/total testosterone ratio (p<0.05) were increased. Negative correlation between 25-hydroxyvitamin-D (r=-0.21, p=0.05) and free androgen index (r=-0.23, p<0.05) with the risk was detected. ROC curve analysis revealed that among tested steroids 25-hydroxyvitamin-D exhibited highest area under curve (AUC 0.69, p<0.001). Multifactorial regression analysis indicated prostate specific antigen (?=0.49, p<0.0001) and 25-hydroxyvitamin-D (?=-0.24, p<0.04) as statistically significant variables related to tumour grade. Conclusion: It might be hypothesized that prostate cancer is associated with disturbances in steroid metabolism. Development of steroid constellations, focused on vitamin-D, could be helpful for the assessment of disease progression and aggressiveness.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR